Taking the drug osimertinib once a day after surgery reduces chance of patients dying by 51%, trials show
A pill taken once a day cuts the risk of dying from lung cancer by half, according to “thrilling” and “unprecedented” results from a decade-long global study.
Taking the drug osimertinib after surgery dramatically reduced the risk of patients dying by 51%, results presented at the world’s largest cancer conference showed.
More Stories
Esports are booming in Africa – but can its infrastructure keep pace?
AI learns to distinguish between aromas of US and Scottish whiskies
Man who falsely claimed to be bitcoin creator sentenced for continuing to sue developers